Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genomic Solutions-naz{GNSL} -- Ignore unavailable to you. Want to Upgrade?

To: smh who wrote (56)	2/16/2001 10:15:05 AM
From: tuck	Respond to of 93

smh, >>Genomic Solutions Files Motion For Summary Judgment Seeking Dismissal of PerkinElmer's Lawsuit ANN ARBOR, Mich., Feb 15, 2001 (BUSINESS WIRE) -- Genomic Solutions Inc. (Nasdaq NM: GNSL chart, msgs), a leading global supplier of automated solutions for genomic and proteomic research, announced that today it filed a motion for summary judgment seeking dismissal of the lawsuit filed by PerkinElmer, Inc. in Delaware Chancery Court on February 12, 2001. "If our motion is granted by the Delaware Chancery Court, as we expect, PerkinElmer's complaint will be dismissed, " said Jeffrey S. Williams, president and chief executive officer of Genomic Solutions. "As we said previously, we believe the PerkinElmer lawsuit is without merit and we intend to defend our rights vigorously and aggressively. We have filed the summary judgment motion in order to achieve a prompt resolution of this matter, which result we believe to be in the best interests of our stakeholders."<< snip Cheers, Tuck